2575 — Xuanzhu Biopharmaceutical Co Balance Sheet
0.000.00%
- HK$9.27bn
- HK$8.52bn
- CNY51.77m
Annual balance sheet for Xuanzhu Biopharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 450 | 246 | 652 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 13.5 | 14.6 | 47.4 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 542 | 369 | 832 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 207 | 172 | 116 |
| Net Intangible Assets | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 1,321 | 1,197 | 1,640 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 143 | 179 | 222 |
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 211 | 240 | 270 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 1,110 | 957 | 1,370 |
| Total Liabilities & Shareholders' Equity | 1,321 | 1,197 | 1,640 |
| Total Common Shares Outstanding |